De Vitry F, Hillion J, Catelon J, Thibault J, Benoliel J J, Hamon M
Groupe de Neuroendocrinologie Cellulaire et Moléculaire, CNRS-URA 1115, Collège de France, Paris.
Brain Res Dev Brain Res. 1991 Apr 24;59(2):123-31. doi: 10.1016/0165-3806(91)90092-w.
Previous studies, aimed at identifying which diffusible signals may influence the differentiation of embryonic neurons towards the monoaminergic phenotypes during brain development, have shown that serotonin itself could promote the 'serotoninergic-like properties' of hypothalamic cells from mouse embryos. We presently reinvestigated such 'autocrine/paracrine' regulatory mechanisms by exposing dissociated cell cultures from embryonic rat hypothalamus and brain stem to dopamine--or related agonists--in an attempt to influence their differentiation towards the catecholaminergic phenotype. Chronic treatment of cells by dopamine or apomorphine (a mixed D1/D2 agonist), but not selective D1 and D2 agonists, significantly increased the number of cells that expressed tyrosine hydroxylase (TH: as assessed with a specific anti-TH antiserum) and the activity of aromatic L-amino acid decarboxylase (AADC) in the cultures. Furthermore, apomorphine treatment also decreased the levels of cholecystokinin-like material in primary cultures from the brainstem (but not the hypothalamus) where both dopamine and cholecystokinin are--partly--colocalized in mesencephalic dopaminergic neurons. The maximal effects of both dopamine and apomorphine on TH expression and AADC activity occurred earlier in the brainstem (on cells from 14- to 15-day-old embryos) than in the hypothalamus (on cells from 15- to 16-day-old embryos), in line with the well established caudo-rostral maturation of the rat brain. Furthermore both the expression and the dopamine-induced modulation of AADC activity and TH immunoreactivity appeared to occur independently of each other. Present and previous data are in agreement with a possible autocrine/paracrine action of dopamine and serotonin during brain development.(ABSTRACT TRUNCATED AT 250 WORDS)
以往的研究旨在确定在大脑发育过程中,哪些可扩散信号可能影响胚胎神经元向单胺能表型的分化,这些研究表明,血清素本身可促进小鼠胚胎下丘脑细胞的“类血清素能特性”。我们目前通过将来自胚胎大鼠下丘脑和脑干的解离细胞培养物暴露于多巴胺或相关激动剂中,重新研究了这种“自分泌/旁分泌”调节机制,试图影响它们向儿茶酚胺能表型的分化。用多巴胺或阿扑吗啡(一种混合的D1/D2激动剂)对细胞进行长期处理,但不是选择性D1和D2激动剂,可显著增加培养物中表达酪氨酸羟化酶(TH:用特异性抗TH抗血清评估)的细胞数量以及芳香族L-氨基酸脱羧酶(AADC)活性。此外,阿扑吗啡处理还降低了脑干(而非下丘脑)原代培养物中胆囊收缩素样物质的水平,在中脑多巴胺能神经元中,多巴胺和胆囊收缩素部分共定位。多巴胺和阿扑吗啡对TH表达和AADC活性的最大影响在脑干(14至15日龄胚胎的细胞)中比在下丘脑(15至16日龄胚胎的细胞)中出现得更早,这与大鼠脑既定的尾-头向成熟一致。此外,AADC活性和TH免疫反应性的表达以及多巴胺诱导的调节似乎彼此独立发生。目前和以往的数据都表明,多巴胺和血清素在大脑发育过程中可能存在自分泌/旁分泌作用。(摘要截短至250字)